Global Natural Killer Cell Therapies Market Insights, Forecast to 2025

Global Natural Killer Cell Therapies Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Natural Killer Cell Therapies Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Natural Killer Cell Therapies Market Size Growth Rate by Type
1.4.2 NK Cell Therapies
1.4.3 NK Cell Directed Antibodies
1.5 Market by Application
1.5.1 Global Natural Killer Cell Therapies Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Gastrointestinal Diseases
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Natural Killer Cell Therapies Market Size
2.1.1 Global Natural Killer Cell Therapies Revenue 2014-2025
2.1.2 Global Natural Killer Cell Therapies Sales 2014-2025
2.2 Natural Killer Cell Therapies Growth Rate by Regions
2.2.1 Global Natural Killer Cell Therapies Sales by Regions
2.2.2 Global Natural Killer Cell Therapies Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Natural Killer Cell Therapies Sales by Manufacturers
3.1.1 Natural Killer Cell Therapies Sales by Manufacturers
3.1.2 Natural Killer Cell Therapies Sales Market Share by Manufacturers
3.2 Natural Killer Cell Therapies Revenue by Manufacturers
3.2.1 Natural Killer Cell Therapies Revenue by Manufacturers (2014-2019)
3.2.2 Natural Killer Cell Therapies Revenue Share by Manufacturers (2014-2019)
3.3 Natural Killer Cell Therapies Price by Manufacturers
3.4 Natural Killer Cell Therapies Manufacturing Base Distribution, Product Types
3.4.1 Natural Killer Cell Therapies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Natural Killer Cell Therapies Product Type
3.4.3 Date of International Manufacturers Enter into Natural Killer Cell Therapies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Natural Killer Cell Therapies Sales by Type
4.2 Global Natural Killer Cell Therapies Revenue by Type
4.3 Natural Killer Cell Therapies Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Natural Killer Cell Therapies Breakdown Data by Application
6 North America
6.1 North America Natural Killer Cell Therapies by Country
6.1.1 North America Natural Killer Cell Therapies Sales by Country
6.1.2 North America Natural Killer Cell Therapies Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Natural Killer Cell Therapies by Type
6.3 North America Natural Killer Cell Therapies by Application
7 Europe
7.1 Europe Natural Killer Cell Therapies by Country
7.1.1 Europe Natural Killer Cell Therapies Sales by Country
7.1.2 Europe Natural Killer Cell Therapies Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Natural Killer Cell Therapies by Type
7.3 Europe Natural Killer Cell Therapies by Application
8 Asia Pacific
8.1 Asia Pacific Natural Killer Cell Therapies by Region
8.1.1 Asia Pacific Natural Killer Cell Therapies Sales by Region
8.1.2 Asia Pacific Natural Killer Cell Therapies Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.2 Asia Pacific Natural Killer Cell Therapies by Type
8.3 Asia Pacific Natural Killer Cell Therapies by Application
9 Central & South America
9.1 Central & South America Natural Killer Cell Therapies by Country
9.1.1 Central & South America Natural Killer Cell Therapies Sales by Country
9.1.2 Central & South America Natural Killer Cell Therapies Revenue by Country
9.1.3 Brazil
9.2 Central & South America Natural Killer Cell Therapies by Type
9.3 Central & South America Natural Killer Cell Therapies by Application
10 Middle East and Africa
10.1 Middle East and Africa Natural Killer Cell Therapies by Country
10.1.1 Middle East and Africa Natural Killer Cell Therapies Sales by Country
10.1.2 Middle East and Africa Natural Killer Cell Therapies Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Natural Killer Cell Therapies by Type
10.3 Middle East and Africa Natural Killer Cell Therapies by Application
11 Company Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Company Business Overview
11.1.3 Nektar Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Nektar Therapeutics Natural Killer Cell Therapies Products Offered
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate
11.2.1 Innate Company Details
11.2.2 Company Business Overview
11.2.3 Innate Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Innate Natural Killer Cell Therapies Products Offered
11.2.5 Innate Recent Development
11.3 Affimed
11.3.1 Affimed Company Details
11.3.2 Company Business Overview
11.3.3 Affimed Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Affimed Natural Killer Cell Therapies Products Offered
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Details
11.4.2 Company Business Overview
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Chipscreen Biosciences Natural Killer Cell Therapies Products Offered
11.4.5 Chipscreen Biosciences Recent Development
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Fate Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Fate Therapeutics Natural Killer Cell Therapies Products Offered
11.5.5 Fate Therapeutics Recent Development
11.6 Glycostem
11.6.1 Glycostem Company Details
11.6.2 Company Business Overview
11.6.3 Glycostem Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Glycostem Natural Killer Cell Therapies Products Offered
11.6.5 Glycostem Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Dragonfly Therapeutics Natural Killer Cell Therapies Products Offered
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Kiadis Pharma Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Kiadis Pharma Natural Killer Cell Therapies Products Offered
11.8.5 Kiadis Pharma Recent Development
11.9 NantWorks
11.9.1 NantWorks Company Details
11.9.2 Company Business Overview
11.9.3 NantWorks Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.9.4 NantWorks Natural Killer Cell Therapies Products Offered
11.9.5 NantWorks Recent Development
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 Nkarta Therapeutics Natural Killer Cell Therapies Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Nkarta Therapeutics Natural Killer Cell Therapies Products Offered
11.10.5 Nkarta Therapeutics Recent Development
11.11 Fortress Biotech
12 Future Forecast
12.1 Natural Killer Cell Therapies Market Forecast by Regions
12.1.1 Global Natural Killer Cell Therapies Sales Forecast by Regions 2019-2025
12.1.2 Global Natural Killer Cell Therapies Revenue Forecast by Regions 2019-2025
12.2 Natural Killer Cell Therapies Market Forecast by Type
12.2.1 Global Natural Killer Cell Therapies Sales Forecast by Type 2019-2025
12.2.2 Global Natural Killer Cell Therapies Revenue Forecast by Type 2019-2025
12.3 Natural Killer Cell Therapies Market Forecast by Application
12.4 North America Natural Killer Cell Therapies Forecast
12.5 Europe Natural Killer Cell Therapies Forecast
12.6 Asia Pacific Natural Killer Cell Therapies Forecast
12.7 Central & South America Natural Killer Cell Therapies Forecast
12.8 Middle East and Africa Natural Killer Cell Therapies Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Natural Killer Cell Therapies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Natural Killer Cell Therapies Product Picture
Table Natural Killer Cell Therapies Market Segments
Table Key Manufacturers Natural Killer Cell Therapies Covered
Table Global Natural Killer Cell Therapies Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Natural Killer Cell Therapies Sales Market Share by Type in 2018 & 2025
Figure NK Cell Therapies Product Picture
Table Major Manufacturers of NK Cell Therapies
Figure NK Cell Directed Antibodies Product Picture
Table Major Manufacturers of NK Cell Directed Antibodies
Table Global Natural Killer Cell Therapies Market Size Growth Rate by Application 2019-2025 (K Units)
Figure Global Natural Killer Cell Therapies 4900 Sales Market Share by Application in 2018
Figure Cancer
Figure Gastrointestinal Diseases
Figure Others
Figure Natural Killer Cell Therapies Report Years Considered
Figure Global Natural Killer Cell Therapies Market Size 2014-2025 (Million US$)
Figure Global Natural Killer Cell Therapies Sales 2014-2025 (K Units)
Table Global Natural Killer Cell Therapies Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Natural Killer Cell Therapies Sales by Regions 2014-2019 (K Units)
Table Global Natural Killer Cell Therapies Sales Market Share by Regions 2014-2019
Figure Global Natural Killer Cell Therapies Sales Market Share by Regions 2014-2019
Figure 2018 Global Natural Killer Cell Therapies Sales Market Share by Regions
Table Global Natural Killer Cell Therapies Revenue by Regions 2014-2019 (Million US$)
Table Global Natural Killer Cell Therapies Revenue Market Share by Regions 2014-2019
Figure Global Natural Killer Cell Therapies Revenue Market Share by Regions 2014-2019
Figure 2018 Global Natural Killer Cell Therapies Revenue Market Share by Regions
Table Global Natural Killer Cell Therapies Sales by Manufacturers (2014-2019) (K Units)
Table Global Natural Killer Cell Therapies Sales Share by Manufacturers (2014-2019)
Figure Global Natural Killer Cell Therapies Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Natural Killer Cell Therapies Revenue by Manufacturers (2014-2019) (Million USD)
Table Natural Killer Cell Therapies Revenue Share by Manufacturers (2014-2019)
Figure Natural Killer Cell Therapies Value Share by Manufacturers in 2018
Table Key Manufacturers Natural Killer Cell Therapies Price (2014-2019) (USD/Unit)
Table Natural Killer Cell Therapies Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Natural Killer Cell Therapies Product Type
Table Date of International Manufacturers Enter into Natural Killer Cell Therapies Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Global Natural Killer Cell Therapies Sales Share by Type (2014-2019)
Figure Global Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure Global Natural Killer Cell Therapies Sales Market Share by Type in 2018
Table Global Natural Killer Cell Therapies Revenue by Type (2014-2019) (Million US$)
Table Global Natural Killer Cell Therapies Revenue Share by Type (2014-2019)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Type (2014-2019)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Type in 2018
Table Natural Killer Cell Therapies Price by Type 2014-2019 (USD/Unit)
Table Global Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Global Natural Killer Cell Therapies Sales Share by Application (2014-2019)
Figure Global Sales Natural Killer Cell Therapies Market Share by Application (2014-2019)
Figure Global Sales Natural Killer Cell Therapies Market Share by Application in 2018
Figure North America Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure North America Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table North America Natural Killer Cell Therapies Sales by Country (2014-2019) (K Units)
Table North America Natural Killer Cell Therapies Sales Market Share by Country (2014-2019)
Figure 2018 North America Natural Killer Cell Therapies Sales Market Share by Country
Table North America Natural Killer Cell Therapies Revenue by Country (2014-2019) (Million US$)
Table North America Natural Killer Cell Therapies Revenue Market Share by Country (2014-2019)
Figure 2018 North America Natural Killer Cell Therapies Revenue Market Share by Country
Figure United States Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure United States Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Canada Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Table North America Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table North America Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure 2018 North America Natural Killer Cell Therapies Market Share by Type
Table North America Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table North America Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure 2018 North America Natural Killer Cell Therapies Market Share by Application
Figure Europe Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure Europe Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Natural Killer Cell Therapies Sales by Country (2014-2019) (K Units)
Table Europe Natural Killer Cell Therapies Sales Market Share by Country (2014-2019)
Figure 2018 Europe Natural Killer Cell Therapies Sales Market Share by Country
Table Europe Natural Killer Cell Therapies Revenue by Country (2014-2019) (Million US$)
Table Europe Natural Killer Cell Therapies Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Natural Killer Cell Therapies Revenue Market Share by Country
Figure Germany Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Germany Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure France Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure France Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure UK Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Italy Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Russia Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Europe Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure 2018 Europe Natural Killer Cell Therapies Market Share by Type
Table Europe Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Europe Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure 2018 Europe Natural Killer Cell Therapies Market Share by Application
Figure Asia Pacific Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Natural Killer Cell Therapies Sales by Region (2014-2019) (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Natural Killer Cell Therapies Sales Market Share by Region
Table Asia Pacific Natural Killer Cell Therapies Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific Natural Killer Cell Therapies Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Natural Killer Cell Therapies Revenue Market Share by Country
Figure China Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure China Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Japan Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure South Korea Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure India Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure India Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Natural Killer Cell Therapies Market Share by Type
Table Asia Pacific Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Asia Pacific Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Natural Killer Cell Therapies Market Share by Application
Figure Central & South America Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Natural Killer Cell Therapies Sales by Country (2014-2019) (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Natural Killer Cell Therapies Sales Market Share by Country
Table Central & South America Natural Killer Cell Therapies Revenue by Country (2014-2019) (Million US$)
Table Central & South America Natural Killer Cell Therapies Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Natural Killer Cell Therapies Revenue Market Share by Country
Figure Brazil Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Natural Killer Cell Therapies Market Share by Type
Table Central & South America Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Central & South America Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Natural Killer Cell Therapies Market Share by Application
Figure Middle East and Africa Natural Killer Cell Therapies Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Natural Killer Cell Therapies Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Natural Killer Cell Therapies Sales by Country (2014-2019) (K Units)
Table Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Country
Table Middle East and Africa Natural Killer Cell Therapies Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Natural Killer Cell Therapies Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Natural Killer Cell Therapies Revenue Market Share by Country
Figure Turkey Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Natural Killer Cell Therapies Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Natural Killer Cell Therapies Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Natural Killer Cell Therapies Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Natural Killer Cell Therapies Market Share by Type
Table Middle East and Africa Natural Killer Cell Therapies Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Natural Killer Cell Therapies Market Share by Application
Table Nektar Therapeutics Company Details
Table Nektar Therapeutics Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nektar Therapeutics Recent Development
Table Innate Company Details
Table Innate Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Innate Recent Development
Table Affimed Company Details
Table Affimed Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Affimed Recent Development
Table Chipscreen Biosciences Company Details
Table Chipscreen Biosciences Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Chipscreen Biosciences Recent Development
Table Fate Therapeutics Company Details
Table Fate Therapeutics Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Fate Therapeutics Recent Development
Table Glycostem Company Details
Table Glycostem Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Glycostem Recent Development
Table Dragonfly Therapeutics Company Details
Table Dragonfly Therapeutics Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dragonfly Therapeutics Recent Development
Table Kiadis Pharma Company Details
Table Kiadis Pharma Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kiadis Pharma Recent Development
Table NantWorks Company Details
Table NantWorks Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table NantWorks Recent Development
Table Nkarta Therapeutics Company Details
Table Nkarta Therapeutics Natural Killer Cell Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nkarta Therapeutics Recent Development
Table Fortress Biotech Company Details
Table Global Natural Killer Cell Therapies Sales Forecast by Regions 2019-2025 (K Units)
Table Global Natural Killer Cell Therapies Sales Market Share Forecast by Regions 2019-2025
Table Global Natural Killer Cell Therapies Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Natural Killer Cell Therapies Revenue Market Share Forecast by Regions 2019-2025
Table Global Natural Killer Cell Therapies Sales Forecast by Type 2019-2025 (K Units)
Table Global Natural Killer Cell Therapies Sales Market Share Forecast by Type 2019-2025
Table Global Natural Killer Cell Therapies Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Natural Killer Cell Therapies Revenue Market Share Forecast by Type 2019-2025
Table Global Natural Killer Cell Therapies Sales Forecast by Application 2019-2025 (K Units)
Table Global Natural Killer Cell Therapies Sales Market Share Forecast by Application 2019-2025
Figure North America Natural Killer Cell Therapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Natural Killer Cell Therapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Natural Killer Cell Therapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Natural Killer Cell Therapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Natural Killer Cell Therapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Natural Killer Cell Therapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Natural Killer Cell Therapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Natural Killer Cell Therapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Natural Killer Cell Therapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Natural Killer Cell Therapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Natural Killer Cell Therapies Value Chain
Table Natural Killer Cell Therapies Customers List
Figure Channels of Distribution
Table Natural Killer Cell Therapies Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs